WHAT'S NEW -- July 1999

Neurologists Lack Pain Management Training
Is Postherpetic Neuralgia More Than One Condition?
Multidisciplinary Headache Treatment Is Effective
Genetics of Pain
Assessment of Diagnostic Criteria for Complex Regional Pain Syndrome (CRPS)
Back to Archive

Neurologists Lack Pain Management Training

A recent study performed by one of our departmental faculty evaluated the pain management education that practicing neurologists obtain in the residency training. Three hundred and thirteen randomly selected neurologists across the United States responded to this survey study. Only 30% of these neurologists reported being adequately trained to diagnose pain disorders and only 20% felt adequately trained to treat pain disorders. Approximately 90% of respondents stated that more pain management education needs to be given to neurology residents (doctors in training) and to neurologists currently in practice.

Galer BS, Keran C, Frisinger M. Pain medicine education among American neurologists: A need for improvement. Neurology 1999, 52:1710-1712.

Editor's Note: Even though neurologists are often expected to be the "pain specialist" in a community, the unfortunate fact is that most neurologists do not obtain any specific pain management training. Importantly, neurologists are acknowledging a need for more education regarding pain management.



Is Postherpetic Neuralgia More Than One Condition?

A most provocative and interesting article was published recently by premier pain researchers from University of California San Francisco, Drs. Michael Rowbotham, Karin Petersen, and Howard Fields. Based on their extensive research experience with postherpetic neuralgia (PHN -- chronic shingles pain), these scientists hypothesize that the pain of PHN may have a variety of different mechanisms and that "the clinical picture of PHN falls into distinct patterns based on differing pathophysiology." They present three different subtypes of PHN, which they feel may respond to different treatments:

1. Irritable Nociceptor subtype = significant allodynia (skin sensitivity)/prolonged relief with local anesthetic injected into the painful skin/increased pain with epinephrine injected into the painful skin/severe burning with capsaicin on the skin;
   
2. Deafferented Nonallodynic subtype = no allodynia/no change with local anesthetic injected into the painful skin/no change with epinephrine injected into the painful skin/no sensation with capsaicin on the skin;
   
3. Deafferented Allodynic subtype = variable allodynia/short term allodynia relief with local anesthetic injected into the painful skin/no significant change with epinephrine injected into the painful skin/variable relief with capsaicin on the skin.

Rowbotham MC, Petersen KL, Fields HL. Is Postherpetic Neuralgia More Than One Disorder? Pain Forum 1998; 7:231-237

Editor's Note: For several years clinical researchers, including this team, have been stating that neuropathic pain disorders, such as PHN, are most likely composed of heterogeneous groups of patients with different pathophysiological mechanisms. This paper is the first attempt to utilize clinical and scientific data and propose such a subgrouping. This hypothesis needs to be further tested in clinical studies before these subtypes are accepted as scientifically valid.



Multidisciplinary Headache Treatment Is Effective

This study assessed the effectiveness of comprehensive headache treatment, which could include aggressive drug therapy, psychological therapy, biofeedback, physical therapy, and anesthesiology techniques; therapy was individually tailored based on initial physician assessment. A questionnaire was mailed to patients 6 months after treatment. These investigators reported significant improvements in frequency of headaches, number of days with work impairment or absence due to headache, less physician visits for headache care, and treatment satisfaction (89% satisfied). As Saper and colleagues concluded, "Öthe results support the concept that matching intensity of treatment (comprehensive/tertiary care) to severity of illness (complex/refractory cases) is cost-effective."

Saper JR, Lake AE, Madden SF, Kreeger C. Comprehensive/Tertiary Care For Headache: A 6-Month Outcome Study. Headache 1999; 39:249-263

Editor's Note: Chronic headache, including migraine, cluster, traumatic, and tension-type headaches, can be very debilitating and require more than just medication treatment. Indeed, many headache patients are currently treated in a "multidisciplinary" method, that is, obtaining many different types of therapies to improve their headache condition, such as medication, psychological therapies, biofeedback, physical therapy, and nerve blocks. This study shows the significant benefits of such a comprehensive treatment approach for the patient and also for society and the health care industry, since patients are able to work more productively and require less doctor visits.



Genetics of Pain

Two studies by Mogil and colleagues assessed the differences in experimental pain models among inbred mouse strains. Using assays for thermal pain, mechanical pain, chemical pain, and neuropathic pain, the investigators observed a unique profile of responsiveness for each different mouse strain. In other words, each mouse strain with a unique genetic make-up responds to each type of pain (for instance, heat vs. nerve injury) in a different manner. The authors conclude that this animal data suggests potentially important avenues for better understanding pain in humans.

Mogil JS et al. Heritability of nociception I: Response of 11 inbred mouse strains on 12 measures of nociception. Pain 1999; 80:67-82.
Mogil JS et al. Heritability of nociception II: 'Types' of nociception revealed by genetic correlation analysis. Pain 1999; 80:83-93.

Editor's Note: These fascinating studies address the potential importance of genetic factors in the human conditions of chronic pain. Why do some people with diabetic neuropathy develop pain and others do not? Why do some people develop postherpetic neuralgia following acute herpes zoster while most do not? It has been shown that some people are genetically predisposed to certain medical conditions (such as diabetes and migraine), so too may some possess certain genes that make them susceptible to chronic pain disorders. Future research is definitely warranted.



Assessment of Diagnostic Criteria for Complex Regional Pain Syndrome (CRPS)

A multicenter study evaluated the current criteria for the diagnosis of Complex Regional Pain Syndrome (CRPS), prior called "reflex sympathetic dystrophy." The results of this study suggest that these criteria are too vague and result in the over-diagnosis of this condition. The study also revealed (as in prior studies) that motor/movement problems are common to CRPS and help differentiate this condition from other chronic pain disorders. The authors' proposed a modified research diagnostic criteria:

1.
Continuing pain which is disproportionate to any inciting event

2.
Must report at least one symptom in each of the four categories:

Sensory
Vasomotor
Sudomotor/edema
Motor/trophic
3.
Must display at least one sign in two or more of the following categories:
 Sensory
 Vasomotor
 Sudomotor/edema
 Motor/trophic

Bruehl S et al. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. Pain 1999; 81:147-154.

Editor's Note: This study is the first large multisite study scientifically assessing the CRPS criteria that were developed by a group of expert clinicians and scientists. Importantly, these criteria were developed with the hope that they would evolve and be improved upon by studies like this one. The goal of diagnostic criteria (particularly in medical conditions where a laboratory test cannot definitively make the diagnosis, as is the case with most medical disorders) is to be able to diagnose CRPS based on the patient's medical history, symptoms and signs (what a doctor finds on the physical examination) with accuracy, that is, statistically distinguish it from other types of neuropathic pain disorders. The results of this study suggest improvements can be made to the existing criteria, as noted above.



BACK TO ARCHIVE OF "WHAT'S NEW"

  ©2000 Continuum Health Partners, Inc.
Disclaimer